Karah Herdman Parschauer - Sep 8, 2022 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role: Director
Signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Stock symbol: TNYA
Transactions as of: Sep 8, 2022
Transactions value $: $0
Form type: 4
Date filed: 9/9/2022, 07:25 PM
Previous filing: Oct 3, 2022
Next filing: Jan 31, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNYA	Stock Option (Right to buy)	Award	$0	+20K		$0.00	20K	Sep 8, 2022	Common Stock	20K	$4.82	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.

Content

Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.